Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 24 for “"BCL2L1"”.
-
The effect of histone deacetylase inhibitors on SRC and BCL2L1 gene expression and a potential role for phosphatases in their transcriptional repression
… being activated, while others like SRC and BCL2L1 are repressed. The mechanism behind HDACi gene expression changes remains unknown; although it has been shown to involve a direct interaction with gene promoters. Using a quantitative qRT-PCR approach, the effect of various HDACi on the …
-
Polymorphismen in Kandidatengenen der Apoptose als genetische Risikofaktoren für Rheumatoide Arthritis
… involviert sind (CFLAR, XIAP, NFKB1, RELA, BCL2L1, FAS, FASLG), selektiert. Innerhalb dieser Gene wurden 23 Einzel-Basen-Polymorphismen (single nucleotide polymorphisms bzw. SNPs) sowie ein Insertions-Deletions-Polymorphismus in 300 französich-kaukasischen Individuen (100 RA-Trio-Familien) …
-
Functions of cDC1 in Mediating CD4+ Help for CD8+ T cells
… in cDC1, including Cd70, Tnfsf9, Ptgs2, and Bcl2l1, and examined their contributions to anti-tumor immunity. We found that cDC1-specific inactivation of CD70 and COX-2, and global CD27 inactivation, only partially impaired tumor rejection or tumor-specific CD8 T-cell expansion. Loss of 4-1BB, …
-
Single Cell Proteogenomics Analysis of AML Samples Treated with Decitabine and Venetoclax Reveals Divergent Treatment Escape Mechanisms
… At relapse, we confirmed the upregulated BCL2L1 in the predominant erythroid compartment in patient who had displayed an erythroid shift. Furthermore, we confirmed the upregulated MCL1 in the monocytic compartments of two patients with monocytic shifts. In one of these patients, scRNAseq …
-
Vitaminas antioxidantes e expressão gênica de biomarcadores cardíacos em pacientes com diferentes níveis de lesão aterosclerótica
… mRNA expression of ALOX15, AREG, BCL2A1, BCL2L1, CA1, COX7B, ECHDC3, IL18R1, IRS2, KCNE1, MMP9, MYL4 and TREML4 were analyzed by RT-qPCR. Alpha-tocopherol level was lower in the 0-4 group compared to the 5-9 group (p=0.035) and showed a positive correlation with BCL2A1 and COX7B mRNA …
-
Role of microRNA 214 in cyclic stretch induced aortic valve pathogenesis
… targets (ATF4) and downstream genes (CHOP and BCL2L1) in porcine AVs ex vivo. Also, the effect of miR-214 overexpression on porcine AV calcification is evaluated. This would give a better understanding on the potential therapeutic role of miR-214 in CAVD.
-
ROLE OF SRPK1-MODULATED ALTERNATIVE SPLICING IN CISPLATIN RESISTANCE IN BREAST CANCER CELLS
… of SRPK1 affects the RNA splicing such as BCL2L1 and MCL1 due to hyperactive SRSFs. Therefore, our study implies that SRPK1 and its relevant splicing regulation could be one of the key mechanisms that result s in chemoresistance to cisplatin in breast cancer cells.
-
Επίδραση ειδικών πρωτεολυτικών ενζύμων στην εξωσωματική παραγωγή και στα ποιοτικά χαρακτηριστικά των εμβρύων αγελάδων
… or survivin, BBC3 or PUMA, PΤGS-2 or COX-2, BCL2L1, SLC2A5 or GLUT-5, MnSOD, PLG and PLAUR); their expression is indicative of embryo quality. For Day 3 and Day 4 embryo gene analysis, another group of genes was selected to be studied (BAX, BCL2L1, PIPOX, G6PD, SLC2A5, MnSOD and KAT2B or …
-
Using Genome-Wide CRISPR/Cas9 Screens to Identify Novel Therapeutic Targets in Small Cell Lung Cancer
… SCLC-specific vulnerabilities like CHEK1 and BCL2L1. Here we show novel SCLC vulnerabilities, specifically focusing on NEDD8 and the neddylation pathway. Perturbation of this pathway causes SCLC death in vitro. Additionally, the SCLC patient derived xenografts models LX108 and RU280 show …
-
Investigating cis- and trans-acting elements involved in regulating fetal hemoglobin gene expression using high throughput genetic data
… expression using the GTEx database and identify BCL2L1 as a new potential trans-regulator of HbF.
-
Einfluss des CDK4/6-Inhibitors Ribociclib auf die periphere Immunantwort beim Hormonrezeptor-positiven Mammakarzinom
… increase in the expression of the genes UBB and BCL2L1. Genes responsible for antigen processing and presentation, as well as genes related to type-I and -III-interferon signaling pathways, were significantly upregulated. In contrast, chemokines that have an immunosuppressive effect were …
-
Análise da expressão gênica na disfunção ventricular após o infarto agudo do miocárdio
… n = 14). Expression of ALOX15, AREG, BCL2A1, BCL2L1, CA1, COX7B, ECHDC3, IL18R1, IRS2, KCNE1, MMP9, MYL4 and TREML4 were updated by RTPCR. Only KCNE1 expression decreased in the LVEF ≤ 40% group (p = 0.007). A positive correlation was found between KCNE1 and ejection fraction (r = 0.557; p = …
-
Functional Genomics identify Novel Therapeutic Vulnerabilities in Retinoblastoma
… cycle arrest. Deleting p21 or applying the BCL2/BCL2L1 inhibitor Navitoclax re-engaged the p53-BAX axis, and synergized with B02, TPT or both to overcome resistance. In addition, the in vivo screens confirmed essentiality of SKP2, a component of the multi-subunit Cullin Ring Ligases (CRLs) that …
-
C-Rel Is A Transcriptional Target of Mesoderm Inducer In Xenopus Like 1 (Mixl1)
… of two anti-apoptotic genes BCL2A1 and BCL2L1 increased under MIXL1 over-expression conditions and decreased under conditions of MIXL1 knockdown by targeted shRNA in U937 cells. In summary, my studies identify c-REL to be a novel mediator of MIXL1-induced survival signals in leukemia.
-
Charakterisierung der Apoptoseinduktion im Rhabdomyosarkommodell: Analyse eines triterpensäurehaltigen Viscum album Gesamtextraktes
… die Proteinexpression von MCL1, BCL2, BCL2L1, XIAP, BIRC5 und CLSPN veränderten. Sie verschoben das Verhältnis zwischen pro- und antiapoptotischen Proteinen zu Gunsten der Apoptose, wobei die Apoptoseinduktion unabhängig von TP53 war. Schlussfolgerung: Zusammenfassend konnte gezeigt …
-
TARGETED THERAPIES FOR EWSR1-FLI1 TRANSLOCATED EWING FAMILY OF TUMORS
… revealing a dual necessity for BCL-2 and BCL-XL (BCL2L1) in EWFT survival. These data reveal BCL-2 and BCL-XL act together to drive olaparib mediated apoptotic resistance in Ewing sarcoma and identify a novel, rational combination therapy using olaparib and the BCL-2/BCL-XL inhibitor navitoclax. …
-
Resistance mechanisms for BCL2-inhibition in acute myeloid leukemia
… regulators including B-Cell Lymphoma 2 Like 1 (BCL2L1 alias BCL-xL), B-Cell Lymphoma 2 related A1 (BCL2A1 alias BFL1) and BCL2 conferred resistance to BCL2-inhibition while their downregulation enhanced sensitivity. Further top hits were Friend Leukemia Integration 1 Transcription Factor (FLI1), …
-
Antiphospholipid antibodies and mechanisms of cell death in the syncytiotrophoblast
… antibodies affect the expression of BCL2L1 (Bcl-2-like 1) and MCL1 (myeloid cell leukomia-1), regulators of the intrinsic pathway of apoptosis, as well as TRAIL (TNF-related apoptosis inducing ligand) a regulator of the extrinsic apoptosis pathway in placental explants. On the …
-
Androgen receptor-mediated growth suppression and apoptosis of human prostate epithelial cells
… analyses reveal that pro-apoptotic genes (BCL2L11/BIM, BOK and AIFM2) are androgen-induced, whereas pro-survival genes (BCL2L1/BCL-XL and MCL1) are androgen-repressed. Hence, we propose that the net effect of these AR-mediated expression changes shifts the balance of BCL2-family proteins in …
-
Therapeutic Vulnerabilities of Venetoclax Resistant Chronic Lymphocytic Leukemia and Novel Treatment Strategies Targeting BCL2/BCL-XL
… CLL cells downregulated BCL2 and gained BCL-XL/BCL2L1 and BIM/BCL2L11 at relapse, which was a phenomenon affecting all clusters, including the most dominant. Moreover, a minor cluster was recurrently expanded in TP53-mutated relapsed CLL with low levels of BCL2 and high NF-KB signaling at …
Page 1 of 2